# SCHOLAR ROCK HOLDING CORPORATION (SRRK) · Edgar & Edgarette company card

> Scholar Rock Holding (SRRK) saw revenue fall 100% in FY2025 to $0 million, operating margin null against a -15.8% median for biological products, (no diagnostic substances), equity 60.7% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1727196 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SRRK) · [JSON](https://www.pops4.com/boards/company/SRRK.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | -100.0% |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -404.8%) |
| Net margin | -Infinity% |
| Operating cash flow | −$300M |
| Capital spending | $602,000 |
| Free cash flow | −$301M |
| Cash | $324M |
| Long-term debt | $100M |
| Total assets | $404M |
| Total equity | $245M |
| Equity ÷ assets | 60.7% |
| Return on equity | -154.0% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -9.91 (distress zone)
- Piotroski F: 1 of 9 (weak)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative (-$300.0M in FY2025); operating loss: a margin of -Infinity% in FY2025

## Edgarette's reading

Exposure: revenue $0K (FY2025), total debt $99.7M. Experience: revenue down 100.0% on the year; operating margin null, down from -404.8%. Soundness: equity 60.7% of assets, return on equity -154.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (31 filers, $50M+ revenue, biological products, (no diagnostic substances)): operating margin null against a -15.8% median; growth -100.0% against 21.4%.

Range logged 2026-09-20, receipt 5ac44694aef3b031, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-09-15 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000110465926107721/0001104659-26-107721-index.htm)
- 8-K · filed 2026-09-14 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000110465926107273/0001104659-26-107273-index.htm)
- 8-K · filed 2026-08-06 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000110465926091702/0001104659-26-091702-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000119312526336732/0001193125-26-336732-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000119312526336715/0001193125-26-336715-index.htm)
- 8-K · filed 2026-06-05 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1727196/000110465926070636/0001104659-26-070636-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001727196.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1727196

## Cite

POPS4, Edgar & Edgarette: SCHOLAR ROCK HOLDING CORPORATION (SRRK) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/SRRK. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.